Previous Page  12 / 12
Information
Show Menu
Previous Page 12 / 12
Page Background

allied

academies

Page 46

Notes:

Journal of Neurology and Neurorehabilitation Research | Volume 4

September 03-04, 2019 | London, UK

Spine and Spinal Disorders

4

th

International Conference on

J Neurol Neurorehabil Res, Volume 4

Preventing development of glucocorticoid-induced Osteoporosis by cod liver oil

Amr S Elbahnasawy

1,2

, E R Valeeva

1

, Eman M El-Sayed

2

and

N V Stepanova

1

1

Kazan Federal University, Russia

2

National Research Centre, Egypt

O

steoporosis is recognized by decreased bone density and

deterioration in bone structure, causing a decrease in

bone strength and an increase in bone fragility and fracture

problems. Glucocorticoids (GCs) are considered as one of

the main reasons of the secondary osteoporosis, and the

resulting fractures cause significant morbidity. fish oil can

decrease bone resorption, inhibit osteoclastogenesis, and

prevent bone resorption. The aim of the current work was

to evaluate the role of cod liver oil in preventing bone loss

and osteoporosis in glucocorticoid-treated rats. The fatty

acids profile of cod liver oil was analyzed, male rats were

fed balanced diet and subdivided into 3 groups, 1- normal

control, 2- prednisolone control, administrated prednisolone

(10 mg/kg po daily); 3- fish oil, administrated prednisolone +

cod liver oil (7% w/w).

Fatty Acid analyses showed that cod liver oil contained high

levels of long chain ω-3 polyunsaturated fatty acids (PUFAs),

eicosapentaenoic acid (EPA) and docosahexaenoic acid

(DHA). Supplementation with cod liver oil helped to improve

calcium levels in plasma and suppress oxidative stress and

inflammatory markers. Additionally, reduced bone resorption

as reflected from the decreased levels of C-terminal

telopeptide and showed significant improvement in bone

mineral density and normal histological results of bone cells

compared to normal and prednisolone control. Our study

indicated that feeding oil rich in PUFAs such as cod liver oil

was able to modulate the potential effect of prednisolone in

bon loss in rats. This may occur through some intracellular

pathways, involving the improvement of calcium absorption,

regulation of bone metabolism and the differentiation of the

osteoblast and osteoclast, suppression of oxidative stress and

modulation of inflammatory response. Therefore, cod liver

oil could be used as a natural approach to help in preventing

bone loss associated with glucocorticoid therapy.

e

:

amelbahnasavi@stud.kpfu.ru